The Potential of MicroRNAs in Personalized Medicine against Cancers

Abstract EN

MicroRNAs orchestrate the expression of the genome and impact many, if not all, cellular processes.

Their deregulation is thus often causative of human malignancies, including cancers.

Numerous studies have implicated microRNAs in the different steps of tumorigenesis including initiation, progression, metastasis, and resistance to chemo/radiotherapies.

Thus, microRNAs constitute appealing targets for novel anticancer therapeutic strategies aimed at restoring their expression or function.

As microRNAs are present in a variety of human cancer types, microRNA profiles can be used as tumor-specific signatures to detect various cancers (diagnosis), to predict their outcome (prognosis), and to monitor their treatment (theranosis).

In this review, we present the different aspects of microRNA biology that make them remarkable molecules in the emerging field of personalized medicine against cancers and provide several examples of their industrial exploitation.